Annual Drug Patent Expirations for INVOKAMET+XR
Invokamet Xr is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
INVOKAMET XR drug price trends.
Drug patent litigation for INVOKAMET XR.
This drug has two hundred and nineteen patent family members in forty-six countries.
The generic ingredient in INVOKAMET XR is canagliflozin; metformin hydrochloride. One supplier is listed for this compound. Additional details are available on the canagliflozin; metformin hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
